Vitamin C and folate status in hereditary fructose intolerance
Cano, A.; Alcalde, C.; Belanger-Quintana, A.; Cañedo-Villarroya, E.; Ceberio, L.; Chumillas-Calzada, S.; Correcher, P.; Couce Pico, María Luz; García-Arenas, D.; Gómez, I.; Hernández, T.; Izquierdo-García, E.; Chicano, D.M.; Morales, M.; Pedrón-Giner, C.; Jáuregui, E.P.; Peña-Quintana, L.; Sánchez Pintos, Paula; Serrano-Nieto, J.; Suarez, M.U.; Miñana, I.V.; de las Heras, J.

Identificadores
Identificadores
Visualización o descarga de ficheros
Visualización o descarga de ficheros
Fecha de publicación
2022Título de revista
European Journal of Clinical Nutrition
Tipo de contenido
Article
Resumen
Background: Hereditary fructose intolerance (HFI) is a rare inborn error of fructose metabolism caused by the deficiency of aldolase B. Since treatment consists of a fructose-, sucrose- and sorbitol-restrictive diet for life, patients are at risk of presenting vitamin deficiencies. Although there is no published data on the status of these vitamins in HFI patients, supplementation with vitamin C and folic acid is common. Therefore, the aim of this study was to assess vitamin C and folate status and supplementation practices in a nationwide cohort of HFI patients. Methods: Vitamin C and folic acid dietary intake, supplementation and circulating levels were assessed in 32 HFI patients and 32 age- and sex-matched healthy controls. Results: Most of the HFI participants presented vitamin C (96.7%) and folate (90%) dietary intake below the recommended population reference intake. Up to 69% received vitamin C and 50% folic acid supplementation. Among HFI patients, 15.6% presented vitamin C and 3.1% folate deficiency. The amount of vitamin C supplementation and plasma levels correlated positively (R = 0.443; p = 0.011). Interestingly, a higher percentage of non-supplemented HFI patients were vitamin C deficient when compared to supplemented HFI patients (30% vs. 9.1%; p = 0.01) and to healthy controls (30% vs. 3.1%; p < 0.001). Conclusions: Our results provide evidence for the first time supporting vitamin C supplementation in HFI. There is great heterogeneity in vitamin supplementation practices and, despite follow-up at specialised centres, vitamin C deficiency is common. Further research is warranted to establish optimal doses of vitamin C and the need for folic acid supplementation in HFI.
